Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire
Evan R. Abt(Sylvester Comprehensive Cancer Center), Ting Wu(Xiamen University)
Cited by 5
Related Papers
Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials
|The Lancet Respiratory Medicine|2022|140
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial
|Science Bulletin|2023|26
Active surveillance of hepatitis E: a 10-year epidemiological analysis in a city in eastern China
|Emerging Microbes & Infections|2024|11
Long-term protection from naturally acquired immunity against hepatitis E virus reinfection
|Nature Communications|2025|0
Synthetic lethality between RB-loss and E2F3 inhibition in small cell cancers targeted by pyrimidine synthesis blockade
|Proceedings of the National Academy of Sciences|2026|0